Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune effector mechanisms in myocardial pathologies.

O Binah1

  • 1Rappaport Institute, P.O. Box 9697, Haifa 31096, Israel.

International Journal of Molecular Medicine
|June 14, 2000
PubMed
Summary

Immune cells can harm heart muscle cells through apoptosis or non-apoptotic damage. This review explores how immune responses may cause lasting, non-lethal heart cell injury, leading to cardiac dysfunction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impulse conduction and gap junctional remodelling by endothelin-1 in cultured neonatal rat ventricular myocytes.

Journal of cellular and molecular medicine·2009
Same author

Mechanical load induced by glass microspheres releases angiogenic factors from neonatal rat ventricular myocytes cultures and causes arrhythmias.

Journal of cellular and molecular medicine·2008
Same author

Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes.

Journal of cardiovascular electrophysiology·2002
Same author

Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.

The Journal of clinical investigation·2001
Same author

Pharmacologic modulation of the immune interaction between cytotoxic lymphocytes and ventricular myocytes.

Journal of cardiovascular pharmacology·2001
Same author

Electrophysiologic perturbations and arrhythmogenic activity caused by activation of the Fas receptor in murine ventricular myocytes: role of the inositol trisphosphate pathway.

Journal of cardiovascular electrophysiology·2001

Area of Science:

  • Immunology
  • Cardiology
  • Cell Biology

Background:

  • Immune effector mechanisms are implicated in cardiac dysfunction in diseases like myocarditis, transplant rejection, and Chagas' disease.
  • Cellular immunity plays a significant role in heart pathologies, contributing to global morbidity and mortality.
  • Two primary lymphocytotoxicity mechanisms are proposed: secretory (perforin/granzymes) and non-secretory (Fas/FasL).

Purpose of the Study:

  • To review the concept of non-apoptotic consequences of cytotoxic T lymphocyte (CTL)-myocyte interactions.
  • To explore how CTL-myocyte interactions can lead to sustained myocyte damage beyond programmed cell death.

Main Methods:

  • Literature review of studies on immune effector mechanisms in cardiac dysfunction.
  • Analysis of proposed mechanisms of lymphocytotoxicity (secretory and non-secretory).
  • Discussion of factors influencing CTL-myocyte interaction outcomes.

Main Results:

  • While apoptotic cell death is a known outcome, CTL-myocyte interaction can also induce non-apoptotic damage.
  • The outcome depends on myocyte status and the balance of pro- and anti-apoptotic factors.
  • This non-apoptotic damage can be sustained and potentially reversible, contributing to immune-mediated cardiac dysfunction.

Conclusions:

  • Immune-mediated cardiac dysfunction may involve non-apoptotic damage to myocytes.
  • Understanding these non-lethal effects is crucial for comprehending heart disease pathogenesis.
  • Further research into non-apoptotic pathways could reveal new therapeutic targets for heart diseases.

Related Experiment Videos